Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

PEGylated Cationic Serum Albumin for Boosting Retroviral Gene Transfer.

Palesch D, Boldt F, Müller JA, Eisele K, Stürzel CM, Wu Y, Münch J, Weil T.

Chembiochem. 2016 Aug 17;17(16):1504-8. doi: 10.1002/cbic.201600193. Epub 2016 Jul 14.

PMID:
27239020
2.

Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy-Resistant Breast Cancer.

Wardell SE, Ellis MJ, Alley HM, Eisele K, VanArsdale T, Dann SG, Arndt KT, Primeau T, Griffin E, Shao J, Crowder R, Lai JP, Norris JD, McDonnell DP, Li S.

Clin Cancer Res. 2015 Nov 15;21(22):5121-5130. doi: 10.1158/1078-0432.CCR-15-0360. Epub 2015 May 19.

3.

Axitinib and crizotinib combination therapy inhibits bone loss in a mouse model of castration resistant prostate cancer.

Eswaraka J, Giddabasappa A, Han G, Lalwani K, Eisele K, Feng Z, Affolter T, Christensen J, Li G.

BMC Cancer. 2014 Oct 2;14:742. doi: 10.1186/1471-2407-14-742.

4.

Efficient delivery of p53 and cytochrome c by supramolecular assembly of a dendritic multi-domain delivery system.

Ng DY, Fahrer J, Wu Y, Eisele K, Kuan SL, Barth H, Weil T.

Adv Healthc Mater. 2013 Dec;2(12):1620-9. doi: 10.1002/adhm.201200419. Epub 2013 May 8.

PMID:
23657926
5.

A core-shell albumin copolymer nanotransporter for high capacity loading and two-step release of doxorubicin with enhanced anti-leukemia activity.

Wu Y, Ihme S, Feuring-Buske M, Kuan SL, Eisele K, Lamla M, Wang Y, Buske C, Weil T.

Adv Healthc Mater. 2013 Jun;2(6):884-94. doi: 10.1002/adhm.201200296. Epub 2012 Dec 7.

PMID:
23225538
6.

A quantum dot photoswitch for DNA detection, gene transfection, and live-cell imaging.

Wu Y, Eisele K, Doroshenko M, Algara-Siller G, Kaiser U, Koynov K, Weil T.

Small. 2012 Nov 19;8(22):3465-75. doi: 10.1002/smll.201200409. Epub 2012 Aug 23.

PMID:
22915540
7.

Convenient approach to polypeptide copolymers derived from native proteins.

Wu Y, Pramanik G, Eisele K, Weil T.

Biomacromolecules. 2012 Jun 11;13(6):1890-8. doi: 10.1021/bm300418r. Epub 2012 May 15.

PMID:
22559216
8.

Bioactive unnatural somatostatin analogues through bioorthogonal iodo- and ethynyl-disulfide intercalators.

Pfisterer A, Eisele K, Chen X, Wagner M, Müllen K, Weil T.

Chemistry. 2011 Aug 22;17(35):9697-707. doi: 10.1002/chem.201100287. Epub 2011 Jul 11.

PMID:
21748812
9.

Tailored Albumin-based Copolymers for Receptor-Mediated Delivery of Perylenediimide Guest Molecules.

Eisele K, Gropeanu R, Musante A, Glasser G, Li C, Muellen K, Weil T.

Macromol Rapid Commun. 2010 Sep 1;31(17):1501-8. doi: 10.1002/marc.201000176. Epub 2010 Aug 5.

PMID:
21567558
10.

Studies on the dissociation of botulinum neurotoxin type A complexes.

Eisele KH, Fink K, Vey M, Taylor HV.

Toxicon. 2011 Mar 15;57(4):555-65. doi: 10.1016/j.toxicon.2010.12.019. Epub 2010 Dec 30.

PMID:
21195107
11.

Cationized albumin-biocoatings for the immobilization of lipid vesicles.

Ritz S, Eisele K, Dorn J, Ding S, Vollmer D, Pütz S, Weil T, Sinner EK.

Biointerphases. 2010 Sep;5(3):FA78-87. doi: 10.1116/1.3494039.

PMID:
21171717
12.

cBSA-147 for the preparation of bacterial biofilms in a microchannel reactor.

Ng JF, Jaenicke S, Eisele K, Dorn J, Weil T.

Biointerphases. 2010 Sep;5(3):FA41-7. doi: 10.1116/1.3474475.

PMID:
21171712
13.

Fine-tuning DNA/albumin polyelectrolyte interactions to produce the efficient transfection agent cBSA-147.

Eisele K, Gropeanu RA, Zehendner CM, Rouhanipour A, Ramanathan A, Mihov G, Koynov K, Kuhlmann CR, Vasudevan SG, Luhmann HJ, Weil T.

Biomaterials. 2010 Nov;31(33):8789-801. doi: 10.1016/j.biomaterials.2010.07.088.

PMID:
20817248
14.

Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide.

Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Koka S, Eisele K, Klarl BA, Rübben H, Schmid KW, Mann K, Hildenbrand S, Hefter H, Huber SM, Wieder T, Erhardt A, Häussinger D, Gulbins E, Lang F.

Nat Med. 2007 Feb;13(2):164-70. Epub 2007 Jan 28.

PMID:
17259995
15.

Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel.

Lang PA, Huober J, Bachmann C, Kempe DS, Sobiesiak M, Akel A, Niemoeller OM, Dreischer P, Eisele K, Klarl BA, Gulbins E, Lang F, Wieder T.

Cell Physiol Biochem. 2006;18(1-3):151-64. Epub 2006 Aug 15.

16.

Protein kinase C mediates erythrocyte "programmed cell death" following glucose depletion.

Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, Sobiesiak M, Eisele K, Podolski M, Huber SM, Wieder T, Lang F.

Am J Physiol Cell Physiol. 2006 Jan;290(1):C244-53.

17.

Inhibition of erythrocyte "apoptosis" by catecholamines.

Lang PA, Kempe DS, Akel A, Klarl BA, Eisele K, Podolski M, Hermle T, Niemoeller OM, Attanasio P, Huber SM, Wieder T, Lang F, Duranton C.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Nov;372(3):228-35. Epub 2005 Oct 25.

PMID:
16247607
18.

Phage release from biofilm and planktonic Staphylococcus aureus cells.

Resch A, Fehrenbacher B, Eisele K, Schaller M, Götz F.

FEMS Microbiol Lett. 2005 Nov 1;252(1):89-96. Epub 2005 Sep 15.

19.

Stimulation of erythrocyte phosphatidylserine exposure by mercury ions.

Eisele K, Lang PA, Kempe DS, Klarl BA, Niemöller O, Wieder T, Huber SM, Duranton C, Lang F.

Toxicol Appl Pharmacol. 2006 Jan 1;210(1-2):116-22. Epub 2005 Aug 31.

PMID:
16137732
20.

Stimulation of erythrocyte ceramide formation by platelet-activating factor.

Lang PA, Kempe DS, Tanneur V, Eisele K, Klarl BA, Myssina S, Jendrossek V, Ishii S, Shimizu T, Waidmann M, Hessler G, Huber SM, Lang F, Wieder T.

J Cell Sci. 2005 Mar 15;118(Pt 6):1233-43. Epub 2005 Mar 1.

21.

Stimulation of erythrocyte phosphatidylserine exposure by lead ions.

Kempe DS, Lang PA, Eisele K, Klarl BA, Wieder T, Huber SM, Duranton C, Lang F.

Am J Physiol Cell Physiol. 2005 Feb;288(2):C396-402.

22.
23.

Oxygen-dependent regulation of in vivo replication of simian virus 40 DNA is modulated by glucose.

Riedinger HJ, van Betteraey-Nikoleit M, Hilfrich U, Eisele KH, Probst H.

J Biol Chem. 2001 Dec 14;276(50):47122-30. Epub 2001 Oct 17.

24.

A low-molecular-weight cytosolic inhibitor of the specific testosterone binding in bovine seminal vesicles.

Oberste-Frielinghaus HR, Burger M, Rapior N, Taylor HV, Eisele K.

Biochem Biophys Res Commun. 2000 Sep 24;276(2):483-7.

PMID:
11027501
25.

Molecular symmetry of the dodecamer subunit of Lumbricus terrestris hemoglobin.

Martin PD, Eisele KL, Doyle MA, Kuchumov AR, Walz DA, Arutyunyan EG, Vinogradov SN, Edwards BF.

J Mol Biol. 1996 Jan 12;255(1):170-5.

PMID:
8568864
26.

A biotin-streptavidin amplified enzymeimmunoassay for 13,14-dihydro-15-keto-PGF2 alpha.

Meyer HH, Eisele K, Osaso J.

Prostaglandins. 1989 Sep;38(3):375-83.

PMID:
2675197
27.

Effects of available P and N:P ratios on non-symbiotic dinitrogen fixation in tallgrass prairie soils.

Eisele KA, Schimel DS, Kapustka LA, Parton WJ.

Oecologia. 1989 Jun;79(4):471-474. doi: 10.1007/BF00378663.

PMID:
28313480
28.

Reactivation of the androgen receptor from murine preputial gland by thioredoxin or GSH.

Wiegand M, Ofenloch-Hähnle B, Eisele K.

J Steroid Biochem. 1989 Jan;32(1A):53-8.

PMID:
2913401
29.

cAMP binds with high affinity and specificity to the androgen receptor from murine skeletal muscle.

Ofenloch-Hähnle B, Eisele K.

Biochemistry. 1988 Nov 15;27(23):8592-8.

PMID:
2851330
31.

Isolation and characterization of the androgen receptor of murine preputial gland.

Wiegand M, Eisele K.

Z Naturforsch C. 1988 Jan-Feb;43(1-2):117-25.

PMID:
3376517
32.

Inhibition of cAMP-phosphodiesterase by molybdate.

Ofenloch-Hähnle B, Eisele K.

Z Naturforsch C. 1987 Jan-Feb;42(1-2):162-4.

PMID:
3033926
33.

In vitro transformation of androgen receptor from murine skeletal muscle by cAMP.

Ofenloch-Hähnle B, Kunst M, Eisele K.

Biochem Biophys Res Commun. 1986 Mar 28;135(3):1069-75.

PMID:
3008739
34.

Piracetam improves visuomotor and cognitive deficits in early Parkinsonism--a pilot study.

Oepen G, Eisele K, Thoden U, Birg W.

Pharmacopsychiatry. 1985 Nov;18(6):343-6.

PMID:
4089014
35.
36.

Androgen receptor complex binding in murine skeletal muscle nuclei.

Vollmer G, Haase A, Eisele K.

Biochem Biophys Res Commun. 1982 Apr 29;105(4):1554-60. No abstract available.

PMID:
6179513
38.

Further studies on the three-step-increase in activity due to the aromatic amino acids B24-26 (-Phe-Phe-Tyr-).

Weitzel G, Bauer FU, Eisele K.

Hoppe Seylers Z Physiol Chem. 1976 Feb;357(2):187-200.

PMID:
1254246
40.

Antibiotically active tripeptides with the sequence L-arginine-N-alpha-methyl-L-X-L-phenylananine.

Eisele A, Eisele K.

FEBS Lett. 1975 Jul 15;55(1):153-5. No abstract available.

41.

[Antibiotically active tripeptides of the sequence L-arg-D-X-L-phe] (author's transl)].

Eisele K.

Experientia. 1975 Jul 15;31(7):764-5. German.

PMID:
1140306
42.

[Sequence variation on an antibiotically active tripeptide (author's transl)].

Eisele K.

Z Naturforsch C. 1975 Jul-Aug;30(4):541-3. German.

PMID:
126596
43.

[Syntheses of oligopeptides related to the insulin sequence B 22-25 (Arg-Gly-Phe-Phe) (author's transl)].

Eisele K.

Hoppe Seylers Z Physiol Chem. 1975 Jun;356(6):845-54. German.

PMID:
1181276
45.

Structure and activity of insulin. XII. Further studies on biologically acitve synthetic fragments of the B-chain.

Weitzel G, Eisele K, Schulz V, Stock W.

Hoppe Seylers Z Physiol Chem. 1973 Mar;354(3):321-30. No abstract available.

PMID:
4803476
46.

Structure and activity of insulin. XI. Biologically active synthetic peptides of the insulin sequence B22-25.

Weitzel G, Eisele K, Guglielmi H, Stock W, Renner R.

Hoppe Seylers Z Physiol Chem. 1971 Dec;352(12):1735-8. No abstract available.

PMID:
5145254
47.

[Structure and activity of insulin. X. Participation of arginine B 22 in the action of insulin].

Weitzel G, Weber U, Martin J, Eisele K.

Hoppe Seylers Z Physiol Chem. 1971 Jul;352(7):1005-13. German. No abstract available.

PMID:
5566051
48.

[Structure and activity of insulin. 8. Exchange of histidine for alanine in synthetic B-chains].

Weitzel G, Weber U, Eisele K, Zollner H, Martin J.

Hoppe Seylers Z Physiol Chem. 1970 Feb;351(2):263-7. German. No abstract available.

PMID:
5461453
49.

[Structure and activity of insulin. VII. Shortened synthetic B-chains].

Weitzel G, Eisele K, Zollner H, Weber U.

Hoppe Seylers Z Physiol Chem. 1969 Nov;350(11):1480-3. German. No abstract available.

PMID:
5391430
50.

[Structure and action of insulin. 3. Synthetic A-chains with varied sequence].

Weber U, Hörnle S, Köhler P, Nagelschneider G, Eisele K, Weitzel G.

Hoppe Seylers Z Physiol Chem. 1968 Apr;349(4):512-4. German. No abstract available.

PMID:
5652064

Supplemental Content

Loading ...
Support Center